Kazia Therapeutics (KZIA) Shares Outstanding (Diluted Average) (2012 - 2025)

Kazia Therapeutics has reported Shares Outstanding (Diluted Average) for 10 years, with the latest figure at $5.29 in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) fell 67.13% year-over-year to $5.29; the trailing twelve-month figure through Dec 2025 stood at $5.29 (down 67.13% YoY), and the FY2013 full-year result was $115.3 million, changed N/A from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $5.29, down from $16.08 in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $6128.0 in Q4 2022, with the low at $5.29 in Q4 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $2136.3 across 4 years, with a median of $1205.9 in 2023.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) tumbled 60.91% — and 2024, when it plunged 99.33%.
• Kazia Therapeutics' Shares Outstanding (Diluted Average) stood at $6128.0 in 2022, then sank by 60.91% to $2395.6 in 2023, then sank by 99.33% to $16.08 in 2024, then sank by 67.13% to $5.29 in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $5.29 (Q4 2025), $16.08 (Q4 2024), and $2395.6 (Q4 2023), per Business Quant data.